Sclerotherapy versus beta blockade: unanticipated anomalies of experimental design.
Conn
H O
HO
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D004932:Esophageal and Gastric Varices / Q000628:therapy*; D006471:Gastrointestinal Hemorrhage / Q000628:therapy*; D006801:Humans; D012107:Research Design; D015911:Sclerotherapy
D000319:Adrenergic beta-Antagonists